Vinorelbine in androgen-independent metastatic prostatic carcinoma—a phase II study

This publication has 18 references indexed in Scilit:

• Phase II trial of bicalutamide in patients with advanced prostate cancer in whom conventional hormonal therapy failed: a Southwest Oncology Group study (SWOG 9235)
  Urology, 2001
• A retrospective analysis of the relationship between changes in serum PSA, palliative response and survival following systemic treatment in a Canadian randomized trial for symptomatic hormone-refractory prostate cancer
  Published by Elsevier ,2001
• Phase II study of vinorelbine in patients with androgen-independent prostate cancer
  Annals of Oncology, 2001
• Chemotherapy in advanced androgen-independent prostate cancer 1990–1999: A decade of progress?
  Annals of Oncology, 2000
• Post-therapy Serum Prostate-Specific Antigen Level and Survival in Patients With Androgen-Independent Prostate Cancer
  JNCI Journal of the National Cancer Institute, 1999
• Effect of carboplatin on response and palliation in hormone-refractory prostate cancer
  Supportive Care in Cancer, 1998
• Change in serum prostate-specific antigen as a marker of response to cytotoxic therapy for hormone-refractory prostate cancer.
  Journal of Clinical Oncology, 1998
• Phase II Study of Estramustine and Vinorelbine in Hormone-Refractory Prostate Carcinoma Patients
  Acta Oncologica, 1998
• The Perceived Adjustment to Chronic Illness Scale (PACIS): a global indicator of coping for operable breast cancer patients in clinical trials
  Supportive Care in Cancer, 1993
• The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology
  JNCI Journal of the National Cancer Institute, 1993